Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-30 · accession 0000950170-24-103070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | 2024-08-30 | SRPT | Estepan Ian Michael | CFO | S - Sale | $137.36 | -5,985 | 33.9K | -15% | -$822.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | S | D | 5,985 | $137.36 | 33,946 | D | — | — | (F1) Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards and other compensation. |